Allergy Therapeutics (Allergy Therapeutics) Other Long Term Assets

: $6.77 Mil (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

Allergy Therapeutics's other long-term assets for the quarter that ended in Dec. 2023 was $6.77 Mil.

Allergy Therapeutics's quarterly other long-term assets declined from Dec. 2022 ($8.58 Mil) to Jun. 2023 ($6.14 Mil) but then increased from Jun. 2023 ($6.14 Mil) to Dec. 2023 ($6.77 Mil).

Allergy Therapeutics's annual other long-term assets declined from Jun. 2021 ($8.08 Mil) to Jun. 2022 ($6.56 Mil) and declined from Jun. 2022 ($6.56 Mil) to Jun. 2023 ($6.14 Mil).

Allergy Therapeutics Other Long Term Assets Historical Data

The historical data trend for Allergy Therapeutics's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allergy Therapeutics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Other Long Term Assets

7.04

7.39

8.08

6.56

6.14

Allergy Therapeutics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Long Term Assets																7.62	6.56	8.58	6.14	6.77

Allergy Therapeutics Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Allergy Therapeutics (Allergy Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Allergy Therapeutics PLC (OTCPK:AGYTF) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

AGY:UK HHU:Germany

Address

Dominion Way, Worthing, West Sussex, GBR, BN14 8SA

Website

https://www.allergytherapeutics.com

Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergies with aluminum-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany and other countries.